While ZNF768 in our cohort was exclusively specific (100%) for CRC; the addition of ZNF346 resulted in a reduction in specificity to 94.3% and extending the panel further with ZNF638 and ZNF700 resulted in a cumulative specificity of 91.4% (Table 2). This evidence concerns the gene ZNF700 and colorectal carcinoma.